<?xml version="1.0" encoding="UTF-8"?>
<p>Published and pre-peer reviewed analyses of hydroxychloroquine in the treatment of COVID-19 have argued both for and against the benefit of this medication for the treatment of SARS-CoV-2 infection [
 <xref rid="B5" ref-type="bibr">5</xref>â€“
 <xref rid="B7" ref-type="bibr">7</xref>, 
 <xref rid="B9" ref-type="bibr">9</xref>, 
 <xref rid="B10" ref-type="bibr">10</xref>, 
 <xref rid="B12" ref-type="bibr">12</xref>]. These studies have methodologic limitations that hamper interpretation of the data. The lack of any consistent positive findings would argue against hydroxychloroquine being a potent and effective antiviral agent for the treatment of COVID-19.
</p>
